You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial

Article metrics

Article menu

Download PDFPDF

XML
Ophthalmology
Protocol
Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial

 

Online download statistics by month:

Online download statistics by month: September 2020 to June 2025

AbstractFullPdf
Sep 202076763
Oct 202022320484
Nov 202011010737
Dec 2020777322
Jan 2021797727
Feb 2021787630
Mar 2021877435
Apr 2021878633
May 2021838047
Jun 2021717219
Jul 2021817930
Aug 2021919427
Sep 2021877917
Oct 2021848650
Nov 2021393765
Dec 2021798026
Jan 2022868459
Feb 2022666334
Mar 2022676624
Apr 2022534774
May 2022949137
Jun 2022788037
Jul 2022898127
Aug 202213011933
Sep 202223122351
Oct 202220320829
Nov 202218518938
Dec 202218518520
Jan 202321221219
Feb 202326025624
Mar 202332432228
Apr 202329329521
May 202325025123
Jun 202322822320
Jul 202323923925
Aug 202327327226
Sep 202326126118
Oct 202327026626
Nov 202328328610
Dec 202323022528
Jan 2024554818
Feb 202414613320
Mar 202431431331
Apr 202435435031
May 202423323228
Jun 202418217028
Jul 202421821228
Aug 202424623418
Sep 202420820016
Oct 202424324337
Nov 202419819519
Dec 202420519851
Jan 202511311023
Feb 202513012523
Mar 20251029715
Apr 20251059923
May 2025665726
Jun 202520181
Total916089581719